2024 |
PTC Therapeutics Inc
|
Independent Director |
306.0 K |
-28.3 % |
2023 |
PTC Therapeutics Inc
|
Independent Director |
427.0 K |
-9.0 % |
2022 |
PTC Therapeutics Inc
|
Independent Director |
469.0 K |
-26.6 % |
2021 |
PTC Therapeutics Inc
|
Independent Director |
638.7 K |
21.9 % |
2020 |
PTC Therapeutics Inc
|
Independent Director |
524.0 K |
57.8 % |
2019 |
PTC Therapeutics Inc
|
Independent Director |
332.1 K |
47.9 % |
2018 |
PTC Therapeutics Inc
|
Independent Director |
224.5 K |
62.9 % |
2017 |
PTC Therapeutics Inc
|
Independent Director |
137.8 K |
-47.7 % |
2016 |
PTC Therapeutics Inc
|
Independent Director |
263.7 K |
-61.3 % |
2015 |
PTC Therapeutics Inc
|
Independent Director |
680.6 K |
- |
2015 |
Weis Markets, Inc.
|
- |
67.5 K |
-12.9 % |
2015 |
Weis Markets, Inc.
|
Independent Director |
- |
- |
2014 |
Weis Markets, Inc.
|
Independent Director |
77.5 K |
93.8 % |
2014 |
Premier Inc - Ordinary Shares - Class A
|
Director |
1 K |
- |
2014 |
PTC Therapeutics Inc
|
Independent Director |
- |
- |
2013 |
Weis Markets, Inc.
|
Independent Director |
40 K |
0.0 % |
2012 |
Weis Markets, Inc.
|
Independent Director |
40 K |
0.0 % |
2011 |
Weis Markets, Inc.
|
Independent Director |
40 K |
0.0 % |
2010 |
Weis Markets, Inc.
|
Independent Director |
40 K |
- |
2009 |
Weis Markets, Inc.
|
Director |
- |
- |